Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Director/PDMR Shareholding

22 Sep 2008 15:13

22 September 2008 Surface Transforms plc ("Surface Transforms" or the "Company") Issue and Surrender of share options

The Company announces that it has today granted options over 502,926 ordinary shares to directors of the Company as set out below:

Dr Kevin Johnson 481,707Dr Geoff Gould 21,219

The options have been granted under the Company's Enterprise Management Incentive ('EMI') Scheme and the Company's two Inland Revenue unapproved share option schemes for both executives and non executives. The exercise price will be the calculated using the average closing price for the three days ending 24 September 2008, following which a further announcement confirming the exercise price of these options will be made in due course. The options can be exercised at any time between 24 September 2011 and 24 September 2018.

The Company also announces it has received Deeds of Surrender of Share Options from directors of the Company as set out below:

Dr Kevin Johnson 180,000Dr Geoff Gould 29,000

Following the grants and surrenders detailed above, excluding those issued today, the directors' option holdings will be:

No. of Exercise options price vesting period Dr Kevin Johnson 100,000 21p 30 March 2007 to 29 March 2017 288,000 18.25p 30 June 2008 to 30 June 2018 Dr Geoff Gould 50,000 21p 30 March 2007 to 29 March 2017 86,000 18.25p 30 June 2008 to 30 June 2018ENQUIRIES:Surface Transforms plc Geoff Hall Tel: 0151 356 2141Kevin Johnson John East & Partners Limited Simon Clements Tel: 020 7628 2200 Hansard Group (PR) Tel: 020 7245 1100John Bick/Chris Roberts Redmayne Bentley (Private Client Broker) Lucy Clapham/Simon Flather Tel: 01943 886600

vendor
Date   Source Headline
17th Aug 20225:48 pmRNSExercise of options
13th Jul 20227:00 amRNSGrant of Options
6th Jul 20227:00 amRNSTrading Statement & Sales and Operations Update
30th Jun 20226:21 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement and Sales & Operations Presentation
21st Jun 20227:00 amRNSAdditional Capital Markets Day & Presentation
27th May 20222:46 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSDirector/PDMR Shareholding
23rd May 202210:58 amRNSPosting of Annual Report and Notice of AGM
10th May 202212:05 pmEQSHardman & Co: Hardman Talks Video | Surface Transforms Surface Transforms’ Capital Markets Day presentation with the Board
6th May 202210:43 amRNSPresentation to Mello Investor evening
25th Apr 20224:05 pmEQSHardman & Co Research: Surface Transforms (SCE) Growth rate and visibility enhanced even further
22nd Apr 20227:00 amRNSSurface Transforms plc Ian Cleminson appointment
11th Apr 202211:00 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms Management Presentation and Q&A
4th Apr 20227:00 amRNSPreliminary Results and Notice of AGM
31st Mar 20227:00 amRNSAdditional Capital Markets Day
24th Mar 20229:05 amRNSSecond Price Monitoring Extn
24th Mar 20229:00 amRNSPrice Monitoring Extension
24th Mar 20227:01 amRNSCapital Markets Day
24th Mar 20227:00 amRNSNew OEM 8 Contract for Additional Sales
18th Feb 20227:00 amRNSExercise of options
28th Jan 20227:00 amRNSTrading and operations update
16th Dec 202112:34 pmRNSMichael Cunningham purchase of shares
16th Dec 20217:00 amRNSAnnouncement of contract wins with OEM 6
14th Dec 20217:00 amRNSTrading and operations update
11th Nov 20217:00 amRNSDirector/PDMR Shareholding
10th Nov 20217:00 amRNSDirector/PDMR Shareholding
20th Sep 20214:35 pmEQSHardman & Co Research : Hardman Talks Video | Surface Transforms Management Presentation
13th Sep 20217:00 amRNSHalf-year Financial Report
2nd Sep 20217:01 amRNSNew manufacturing strategy
2nd Sep 20217:00 amRNSContract Award from OEM 5
17th Aug 20217:00 amRNSContract award from OEM 10 and notice of results
8th Jul 20217:00 amRNSTrading and operations update
5th Jul 20213:00 pmRNSExercise of options
9th Jun 20218:45 amEQSHardman & Co Research : Hardman Talks Video| Surface Transforms Management Presentation
2nd Jun 20219:43 amRNSResult of Annual General Meeting
28th May 202111:18 amRNSExercise of Options
27th May 202111:51 amRNSMeet the Directors and Q&A
25th May 20217:00 amRNSDirector Dealing
20th May 20219:30 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms - Q&A with the Board
13th May 20217:00 amRNSDirector Dealing
4th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
22nd Apr 20215:38 pmRNSPDMR Dealing
22nd Apr 20215:33 pmRNSDirector Dealing
19th Apr 20215:46 pmRNSExercise of Options
13th Apr 20217:00 amRNSDirector Dealing
12th Apr 20217:00 amRNSPreliminary Results and Notice of AGM
24th Mar 20217:00 amRNS£1 million loan agreement with LCRCA
15th Mar 20213:55 pmEQSHardman & Co Research: Surface Transforms (SCE): Everything has come together
15th Mar 20217:00 amRNSRetirement of NED & update on preliminary results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.